Circulation Research · 1996 · 148 citations · 28 references
Conditional transgene expression is a potentially useful approach to investigate complex biological systems in vivo. We recently demonstrated that tetracycline-responsive promoters could be employed to achieve regulated, cardiac-specific expression of target genes in transgenic mice. To more fully define the quantitative and spatial parameters associated with tetracycline-regulated gene expression in the heart, we crossed transgenic mice harboring either a firefly luciferase or a nuclear-localized bacterial lacZ target gene with strains expressing a tetracycline-controlled transactivator (tTA) under the regulatory control of 2.9 kb of 5' flanking sequence from the rat alpha-myosin heavy chain gene. Luciferase activity was induced nearly 300-fold in the hearts of binary-transgenic mice compared with mice carrying only the luciferase reporter gene. No significant transactivation was observed in any other tissues examined. Binary transgenics harboring the lacZ reporter gene showed substantial beta-galactosidase activity throughout the heart, but the response of individual cardiac myocytes was heterogeneous. For both reporter genes, tetracycline treatment fully repressed tTA-dependent transactivation. These data provide important insights into the nature of studies that can be successfully addressed using the tetracycline-regulated gene expression system in the heart.
28
MyoD or Myf-5 is required for the formation of skeletal muscle
Michael A. Rudnicki, Patrick N.J. Schnegelsberg, R. H. Stead et al. · Cell · 1993 · 1.7K citations
Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
Paul Hasty, Allan Bradley, Julia H. Morris et al. · Nature · 1993 · 1.4K citations
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Priscilla A. Furth, L St Onge, Hinrich Böger et al. · Proceedings of the National Academy of Sciences · 1994 · 771 citations · Full text
Viral Replication, Transgenic Mouse Models, Tetracycline-responsive Promoter +18